Isomorphic Labs, an AI-driven drug discovery company spun out of Google DeepMind, is reportedly in advanced talks to raise over $2 billion in a new funding round. Thrive Capital, which led Isomorphic Labs' initial funding, is expected to spearhead this round, with Alphabet also participating. This follows a period where Sinovac Biotech reported a slight increase in sales but a net loss due to asset impairment charges, while also securing its Nasdaq listing. AI
影响 Accelerates AI's role in drug discovery, potentially leading to faster development of new therapeutics.
排序理由 Significant funding round for an AI-driven drug discovery company.
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →